causal

RNA drug demand is cyclical with biotech funding

Demand for RNA-based drugs is tied to the mRNA theme in pharma, and funding swings cause customers to shift R&D versus commercialization spend, which shows up in the company's results.

causalpending

Speaker

Marc de Vos

Evidence Quote

“companies focus less on R&D one year and more on commercialization to respond to funding changes.”

Source

Agilent: Back To The Lab— Business Breakdowns
Created: 11/12/2026, 11:55:35 AM

Your notes

Loading notes...